FTSE All-Share

FTSE All-Share handeln
5.520,95 PKT +16,42 PKT +0,30 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
08.06.15 Glencore Outperform BNP PARIBAS
08.06.15 Diageo buy Citigroup Corp.
08.06.15 Rio Tinto Neutral BNP PARIBAS
08.06.15 Diageo Neutral JP Morgan Chase & Co.
08.06.15 Vodafone Group buy UBS AG
05.06.15 Vodafone Group buy S&P Capital IQ
05.06.15 AstraZeneca Neutral Goldman Sachs Group Inc.
05.06.15 HSBC Neutral JP Morgan Chase & Co.
05.06.15 Lloyds Banking Group buy HSBC
04.06.15 GSK Equal-Weight Morgan Stanley
03.06.15 BAT neutral Independent Research GmbH
03.06.15 Glencore buy UBS AG
03.06.15 BT Group Neutral UBS AG
03.06.15 Unilever overweight Barclays Capital
03.06.15 Unilever overweight Barclays Capital
02.06.15 Prudential buy UBS AG
02.06.15 AstraZeneca Neutral JP Morgan Chase & Co.
01.06.15 National Grid Verkaufen Independent Research GmbH
01.06.15 Rio Tinto kaufen JP Morgan Chase & Co.
01.06.15 Lloyds Banking Group kaufen JP Morgan Chase & Co.
01.06.15 BAT kaufen JP Morgan Chase & Co.
01.06.15 HSBC Conviction Buy List Goldman Sachs Group Inc.
01.06.15 AstraZeneca buy UBS AG
29.05.15 Shell (ex Royal Dutch Shell) Neutral UBS AG
29.05.15 Vodafone Group Hold Jefferies & Company Inc.
28.05.15 Prudential Halten Independent Research GmbH
28.05.15 Standard Chartered Underweight Morgan Stanley
28.05.15 Imperial Brands Reduce Nomura
28.05.15 Prudential Neutral Nomura
28.05.15 BP buy Deutsche Bank AG
28.05.15 Shell (ex Royal Dutch Shell) Hold Deutsche Bank AG
28.05.15 London Stock Exchange (LSE) buy Citigroup Corp.
28.05.15 HSBC Neutral UBS AG
27.05.15 Diageo market-perform Bernstein Research
27.05.15 AstraZeneca buy Citigroup Corp.
27.05.15 Glencore Neutral Citigroup Corp.
27.05.15 Rio Tinto Neutral Citigroup Corp.
27.05.15 Glencore Equal-Weight Morgan Stanley
27.05.15 AstraZeneca buy UBS AG
26.05.15 GSK verkaufen JP Morgan Chase & Co.